Search for: "GlaxoSmithKline LLC"
Results 101 - 120
of 181
Sorted by Relevance
|
Sort by Date
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
16 Mar 2021, 6:00 am
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
18 Jul 2012, 10:16 am
Cole stated that "the Justice Department and our law enforcement partners have reached an historic $3 billion resolution with the pharmaceutical manufacturer GlaxoSmithKline, LLC, to resolve multiple investigations into the company's sales, marketing, and pricing practices. [read post]
15 May 2023, 7:21 am
GlaxoSmithKline LLC. [read post]
4 Feb 2011, 10:42 am
GlaxoSmithKline LLC, No. 3305, 2011 Phila. [read post]
4 Aug 2011, 1:25 pm
Myers is the owner and President of Myers Injury Law, LLC and a founding partner of Schultz & Myers, LLC. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
1 Oct 2019, 7:00 am
GlaxoSmithKline, LLC. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
17 Apr 2013, 11:03 am
Second, because although we got the legal perspective from moderator, Jayne Navarre, of Law Gravity LLC, we also got an outside perspective from Graham Kahr, Social Scientist with Zappos.com. [read post]
7 Mar 2014, 9:00 am
FMR LLC, which was handed down on Tuesday. [read post]
2 Jan 2015, 10:15 am
MacKay did seek a valuation of his own.But MacKay began to regret the share sale by February 2009, when he learned that Stiefel got two competing bids: one in November 2008 from Sanofi-Aventis ($2.8 billion), and another in March 2009 from GlaxoSmithKline (GSK) ($2.9 billion in cash after an initial bid of $3.1 billion). [read post]
29 Jun 2012, 10:50 am
.'"IN RE: AVANDIA MARKETING, SALES PRACTICES and PRODUCTSLIABILITY LITIGATION GLAXOSMITHKLINE, LLC &GLAXOSMITHKLINE, PLC HUMANA MEDICAL PLAN, INC. and HUMANAINSURANCE COMPANY, individually and on behalf of all others similarlysituated, AppellantsNo. 11-2664UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT2012 U.S. [read post]
5 Sep 2016, 6:46 pm
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
5 Aug 2021, 12:12 pm
GlaxoSmithKline LLC v. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV… [read post]
10 Jun 2010, 3:58 am
LLC et al. v. [read post]
29 Jun 2011, 3:34 am
LLC et al. v. [read post]
11 May 2023, 1:16 pm
GlaxoSmithKline LLC. [read post]